{"id":69475,"url":"https://lda.senate.gov/api/v1/clients/69475/?format=json","client_id":69475,"name":"BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA)","general_description":"Life Sciences R&D","client_government_entity":null,"client_self_select":false,"state":null,"state_display":null,"country":"GB","country_display":"United Kingdom","ppb_state":null,"ppb_state_display":null,"ppb_country":"GB","ppb_country_display":"United Kingdom","effective_date":"2025-09-18","registrant":{"id":401107715,"url":"https://lda.senate.gov/api/v1/registrants/401107715/?format=json","house_registrant_id":56131,"name":"TRUSYNERGY","description":null,"address_1":"50 Oak Lane","address_2":null,"address_3":null,"address_4":null,"city":"Berwyn","state":"PA","state_display":"Pennsylvania","zip":"19312","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK LENKER","contact_telephone":"+1 202-203-0490","dt_updated":"2026-01-09T17:07:36.400372-05:00"}}